In this edition:
Platelet receptor levels differentiate immune from isolated thrombocytopenia
Autologous SCT for autoimmune diseases
Blinatumomab + reduced-intensity chemotherapy for B-ALL
Poor outcome in high BMI patients in ALL06 study
Acute promyelocytic leukaemia and extreme hyperleukocytosis
Lenalidomide after allogeneic HSCT
Markers of long-term survival with oral azacitidine in AML
Daratumumab, bortezomib and dexamethasone in previously treated MM
Ibrutinib + venetoclax for CLL with high-risk genetic features
Asciminib for CML
Please login below to download this issue (PDF)